Getting Ready for the Green Claims Directive
REGISTER HERE
Chemicals in the Spotlight: What PFAS, F-Gases, REACH and Other EU Rules Mean for Generic and Biosimilar Medicines
This session explored key EU chemicals legislation developments, including PFAS restrictions, the revised F-Gas Regulation, and REACH reform, and their potential impact on pharmaceutical manufacturing. Industry and regulatory experts highlighted compliance challenges, substitution issues, and the importance of early preparation.
Trends in the Inclusion of Sustainability Criteria in Procurement
This session examined emerging procurement policies across Europe, with insights from the Czech Ministry of Health, an overview of divergent national approaches (UK, France, Nordics), and company experiences on aligning operations with evolving sustainability requirements.
Principles of Responsible Manufacturing of Antibiotics (AMR Industry Alliance)
The webinar featured insights on certification processes, procurement perspectives from the Nordic Procurement Forum, and practical industry case studies.
EU Deforestation Regulation (EUDR)
Legal experts from Mayer Brown presented an in-depth overview of the EUDR, its scope, due diligence requirements, and compliance challenges, followed by a discussion on best practices.
Implementation of the Corporate Sustainability Reporting Directive (CSRD)
This session explored the implications of the CSRD for our sector, featuring concrete industry experiences.